Daniel van Wamelen (The Maurice Wohl Clinical Neuroscience Institute, King’s College London, UK) discusses non-motor symptoms in Parkinson’s disease (PD) and the repurposing of existing medication in PD to target new areas such as cognition.
Questions
- What are the current unmet needs in the treatment of non-motor symptoms in Parkinson’s disease (PD)? (0:04)
- How important are non-motor symptoms in PD and could you give some examples? (1:49)
- Could you talk a bit about current treatment strategies for non-motor symptoms? (3:09)
View Part 2 of this expert interview here.
Speaker disclosure: Daniel van Wamelen has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting, Philadelphia, USA, May 2019.